Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 14 at 2:00 PM EDT

Register Free →

Supplier of Sodium Chloride 0.9% Injection, USP

Active
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

NAICS

423450 - Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers

Place of Performance

FORT BRAGG, NC, 28310-0000, USA

Set-Aside

NONE

Documents

This scope was carved out of SPE2DP-27-T-0068.

The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

SODIUM CHLORIDE INJECT

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

Posted

subcontract

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
ContactsNo contacts available
OfficeN/A
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Supplies Sodium Chloride 0.9% Injection, USP 500 ML for prime contractors on Medical Supply Chain Pharm FSA projects. Provides product NSN 6505013306268 packaged in sealed unit containers of 24 units per package. Must adhere to FDA regulations and United States Pharmacopeia (USP) specifications. Delivers physical shipments of USP-grade Sodium Chloride Injection in specified quantities.

Similar Contracts

Same NAICS industry code

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

NAICS: 325412
New
DIBBS
ZINC OXIDE OINTMENT
Solicitation # SPE2DP-27-T-0041
Solicitation SPE2DP-27-T-0041, issued by the DLA Troop Support Medical Supply Chain Pharm FSA, is for the procurement of Zinc Oxide Ointment USP. The required product is a topical skin protectant containing 20% zinc oxide, delivered in 1oz (28.4gm) collapsible tubes. The solicitation consists of two line items: CLIN 0001 for 10 units and CLIN 0002 for 5 units. The items must be stored at controlled room temperature not exceeding 30 degrees Celsius (86 degrees Fahrenheit) and have a non-extendable shelf life of 36 months. Delivery is required within 5 days after order, with an original required delivery date of October 2, 2026. Shipping is FOB Destination, with inspection and acceptance also occurring at the destination. The contractor must use the fastest traceable means for shipping and is prohibited from using Parcel Post. Packaging must comply with RP001 DLA Packaging Requirements and MIL-STD-129, with specific medical marking required per Medical Marking Standard No. 1. If the material is deemed hazardous per FED-STD-313, it must follow TQ requirement IP025; otherwise, it shall be commercially packaged per ASTM D3951. The contract incorporates various FAR and DFARS clauses, including requirements for combating trafficking in persons, safeguarding covered defense information, and adherence to the Buy American and Balance of Payments Program for quotes above the micro-purchase threshold. Payment and invoicing must be processed electronically through the Wide Area WorkFlow system. This is an FDA-regulated drug or device, and the contracting official must confirm the product specialist's referral in EBS.
Pharmaceutical Preparation Manufacturing

POSTED

about 23 hours ago

DEADLINE

in 7 days
View Details
NAICS: 325412
New
DIBBS
PROCAINAMIDE HYDROC
Solicitation # SPE2DP-26-T-5314
Solicitation SPE2DP-26-T-5314 is a Request for Quotations issued by the DLA Troop Support Medical Supply Chain Pharm for the procurement of Procainamide Hydrochloride Injection, USP. The requirement is for two packages, with each package containing 25 vials of 100 mg/mL, 10 mL (NSN 6505-01-240-8703). The specified product is manufactured by Pfizer Inc under part number NDC00409-1902-01. The item must have a non-extendable shelf life of 24 months, with at least 21 months remaining upon delivery to the government. Delivery is required within five days after receipt of order, with FOB, inspection, and acceptance all occurring at the destination. The contractor must adhere to strict medical packaging and marking standards, specifically Medical Marking Standard No. 1 and 1C, which supersedes MIL-STD-129. Packaging must be commercial, utilizing suitable sealed unit containers and exterior shipping containers to prevent damage. The solicitation incorporates various FAR and DFARS clauses, including requirements for the Buy American and Balance of Payments Program, safeguarding covered defense information, and hazardous material labeling per 29 CFR 1910.1200. Quotes must be submitted via the DLA Internet Bid Board System by October 5, 2026, and must include the bidder's contact information, manufacturer details, and item description. Payment requests and receiving reports are to be processed electronically through the Wide Area WorkFlow system.
Pharmaceutical Preparation Manufacturing

POSTED

about 23 hours ago

DEADLINE

in 2 days
View Details

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS